The Quality of Life in Heart Failure Reduced Ejection Fraction (HFrEF) Patients: A Phenomenon of Obesity Paradox
DOI:
https://doi.org/10.35898/ghmj-811151Keywords:
Heart failure, HFrEF, Obesity, Obesity paradox, Quality of lifeAbstract
Background: Obesity place patients at risk of cardiovascular disease (CVD). There may be an inverse relationship between obesity and CVD prognosis-a phenomenon known as the “obesity paradox”. Obese HF patients might have a better prognosis, especially in terms of quality of life (QoL).
Aims: The purpose of this study was to examine the QoL of HF patients based on obesity classification.
Methods: This cross-sectional study was conducted at the HF clinic of Hasna Medika Cardiovascular Hospital, Cirebon, Indonesia. Samples were HFrEF patients who had received medication at the HF clinic for at least 6 months and the patient must have received optimal guidelines directed medical therapy (GDMT) with at least 3 pillar drugs according to Indonesian heart failure guidelines. Inclusion criteria were HF patients with ejection fraction <40% on echocardiographic examination. Exclusion criteria were HF patients with motor impairments, such as post-stroke, severe osteoarthritis, paralysis, and patients who did not receive optimal GDMT.
Results: A total of 40.3% sample were obese, 9.7% were underweight and 67.5% had central obesity. Coronary artery disease (89.6%), smoking (67.5%) and hypertension (49.4%) were the most common comorbidities and risk factors found. About 12.3% of sample experienced rehospitalization 3 times a year. Based on Kansas City Cardiomyopathy Questionnaire (KCCQ)-12, about 3.2% of the sample had poor QoL, 55.8% had good QoL and 9.7% had excellent QoL. HFrEF patients with excellent QoL had a proportion of 66.7% obese and 20% overweight. While there were no obese patients in HFrEF patients with poor QoL. The proportion of HFrEF patients with excellent QoL who had central obesity was 80%. Meanwhile, 65.1% of HFrEF patients with good QoL were obese.
Conclusion: Obese HF patients have better QoL outcomes. This phenomenon is called obesity paradox. A good quality of life in HF patients is an important goal of HF management in addition to reducing mortality.
Received: 02 December 2024 | Reviewed: 17 December 2024 |
Revised: 24 December 2024 | Accepted: 10 January 2025.
Downloads
References
Aizawa, Y. (2020). Guidelines for the diagnosis and treatment of acute and chronic heart failure. Journal of Nihon University Medical Association, 79(4), 199–203. https://doi.org/10.4264/numa.79.4_199
Albakri, A. (2018). Heart failure with reduced ejection fraction: A review of clinical status and meta-analyses of diagnosis by 3D echocardiography and natriuretic peptides-guided heart failure therapy. Trends in Research, 1(4). https://doi.org/10.15761/TR.1000122
Chen, X., Xin, Y., Hu, W., Zhao, Y., Zhang, Z., & Zhou, Y. (2019). Quality of life and outcomes in heart failure patients with ejection fractions in different ranges. PLOS ONE, 14(6), e0218983. https://doi.org/10.1371/journal.pone.0218983
Donini, L. M., Pinto, A., Giusti, A. M., Lenzi, A., & Poggiogalle, E. (2020). Obesity or BMI paradox? Beneath the tip of the iceberg. Frontiers in Nutrition, 7, 53. https://doi.org/10.3389/fnut.2020.00053
Fröhlich, H., Frey, N., Frankenstein, L., & Täger, T. (2022). The obesity paradox in heart failure: Is it still valid in light of new therapies? Cardiology, 147(5–6), 529–538. https://doi.org/10.1159/000527332
Golla, M. S. G., Hajouli, S., & Ludhwani, D. (2024). Heart failure and ejection fraction. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK553115/
Hamzeh, N., Ghadimi, F., Farzaneh, R., & Hosseini, K. (2017). Obesity, heart failure, and obesity paradox. The Journal of Tehran University Heart Center, 12(1). https://pmc.ncbi.nlm.nih.gov/articles/PMC5409942/pdf/JTHC-12-1.pdf
Hobbach, A. J., Feld, J., Linke, W. A., Sindermann, J. R., Dröge, P., Ruhnke, T., Günster, C., & Reinecke, H. (2024). Bmi-stratified exploration of the ‘obesity paradox’: Heart failure perspectives from a large German insurance database. Journal of Clinical Medicine, 13(7), 2086. https://doi.org/10.3390/jcm13072086
Horwich, T. B., Fonarow, G. C., & Clark, A. L. (2018). Obesity and the obesity paradox in heart failure. Progress in Cardiovascular Diseases, 61(2), 151–156. https://doi.org/10.1016/j.pcad.2018.05.005
Hweidi, I. M., Al‐Omari, A. K., Rababa, M. J., Al‐Obeisat, S. M., & Hayajneh, A. A. (2021). Cardiac cachexia among patients with chronic heart failure: A systematic review. Nursing Forum, 56(4), 916–924. https://doi.org/10.1111/nuf.12623
Kementerian Kesehatan Republik Indonesia. (2018, November 7). Klasifikasi obesitas setelah pengukuran IMT. https://p2ptm.kemkes.go.id/infographic-p2ptm/obesitas/klasifikasi-obesitas-setelah-pengukuran-imt
Kementerian Kesehatan Republik Indonesia. (2021, October 1). Berikut ini adalah cara mengukur obesitas. https://p2ptm.kemkes.go.id/infographic-p2ptm/obesitas/berikut-ini-adalah-cara-mengukur-obesitas
Khan, A., Van Iterson, E. H., & Laffin, L. J. (2021). The obesity paradox in heart failure: What is the role of cardiorespiratory fitness? Cleveland Clinic Journal of Medicine, 88(8), 449–458. https://doi.org/10.3949/ccjm.88a.20098
Lembo, M., Strisciuglio, T., Fonderico, C., Mancusi, C., Izzo, R., Trimarco, V., Bellis, A., Barbato, E., Esposito, G., Morisco, C., & Rubattu, S. (2024). Obesity: The perfect storm for heart failure. ESC Heart Failure, 11(4), 1841–1860. https://doi.org/10.1002/ehf2.14641
Murphy, S. P., Ibrahim, N. E., & Januzzi, J. L. (2020). Heart failure with reduced ejection fraction: A review. JAMA, 324(5), 488. https://doi.org/10.1001/jama.2020.10262
Pandey, A., Vaduganathan, M., Arora, S., Qamar, A., Mentz, R. J., Shah, S. J., Chang, P. P., Russell, S. D., Rosamond, W. D., & Caughey, M. C. (2020). Temporal trends in prevalence and prognostic implications of comorbidities among patients with acute decompensated heart failure: The aric study community surveillance. Circulation, 142(3), 230–243. https://doi.org/10.1161/CIRCULATIONAHA.120.047019
Rafaqat, S. (2023). Adipokines and their role in heart failure: A literature review. Journal of Innovations in Cardiac Rhythm Management, 14(11), 5657–5669. https://doi.org/10.19102/icrm.2023.14111
Sato, R., & Von Haehling, S. (2023). Revisiting the obesity paradox in heart failure: What is the best anthropometric index to gauge obesity? European Heart Journal, 44(13), 1154–1156. https://doi.org/10.1093/eurheartj/ehad079
Sattar, N., Neeland, I. J., & McGuire, D. K. (2024). Obesity and cardiovascular disease: A new dawn. Circulation, 149(21), 1621–1623. https://doi.org/10.1161/CIRCULATIONAHA.123.065485
Schwinger, R. H. G. (2021). Pathophysiology of heart failure. Cardiovascular Diagnosis and Therapy, 11(1), 263–276. https://doi.org/10.21037/cdt-20-302
Spertus, J. A., Jones, P. G., Sandhu, A. T., & Arnold, S. V. (2020). Interpreting the kansas city cardiomyopathy questionnaire in clinical trials and clinical care. Journal of the American College of Cardiology, 76(20), 2379–2390. https://doi.org/10.1016/j.jacc.2020.09.542
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 dr. Yogi Puji Rachmawan, SpJP., dr. Witri Pratiwi, M.Kes, Dr. dr. Helda, M.Kes

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
GHMJ (Global Health Management Journal) conforms fully to The Budapest Open Access Initiative (BOAI) and DOAJ Open Access Definition. Authors, readers, and reviewers are free to Share ” copy and redistribute the material in any medium or format, and Adapt ” remix, transform, and build upon the material. Author(s) retain unrestricted copyrights and publishing rights of their work. The licensor cannot revoke these freedoms as long as you follow the license terms. Learn the details at the License policy.